Clinical Trial

Application of Remimazolam, Dexmedetomidine, and Esketamine in Pediatric Preoperative Sedation

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 10, 2025 (before its estimated March 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
By comparing the application effects of three drugs in pediatric preoperative sedation, this study explores the optimal medication regimen, aiming to provide safer, more effective, and more personalized medication options for pediatric preoperative sedation. Additionally, this research will also focus on the impact of these three drugs on postoperative agitation in children, offering valuable references for the overall management of pediatric surgical anesthesia.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-06-24.
Trial Details
NCT Number NCT07050212
Lead Sponsor Maternal and Child Health Hospital of Hubei Province
Conditions Remimazolam, Dexmedetomidine, Esketamine
Enrollment 150 participants
Start Date 2025-04-01
Primary Completion 2026-03-01 (estimated)
Study Completion 2026-03-01 (estimated)
Updated on ClinicalTrials.gov 2025-07-10